Cargando…
NS398 as a potential drug for autosomal‐dominant polycystic kidney disease: Analysis using bioinformatics, and zebrafish and mouse models
Autosomal‐dominant polycystic kidney disease (ADPKD) is characterized by uncontrolled renal cyst formation, and few treatment options are available. There are many parallels between ADPKD and clear‐cell renal cell carcinoma (ccRCC); however, few studies have addressed the mechanisms linking them. In...
Autores principales: | Chen, Sixiu, Huang, Linxi, Zhou, Shoulian, Zhang, Qingzhou, Ruan, Mengna, Fu, Lili, Yang, Bo, Xu, Dechao, Mei, Changlin, Mao, Zhiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505825/ https://www.ncbi.nlm.nih.gov/pubmed/34551202 http://dx.doi.org/10.1111/jcmm.16903 |
Ejemplares similares
-
New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol
por: Yang, Bo, et al.
Publicado: (2015) -
Chromatin Methylation Abnormalities in Autosomal Dominant Polycystic Kidney Disease
por: Xu, Jing, et al.
Publicado: (2022) -
Fibroblast Growth Factor 23 Is a Valuable Predictor of Autosomal Dominant Polycystic Kidney Disease Progression
por: Xue, Cheng, et al.
Publicado: (2021) -
Autosomal dominant polycystic kidney disease: recent advances in clinical management
por: Mao, Zhiguo, et al.
Publicado: (2016) -
Plant-derived compounds for treating autosomal dominant polycystic kidney disease
por: Zhang, Jieting, et al.
Publicado: (2023)